J. Stevenhagen

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Persistent phrenic nerve palsy after atrial fibrillation ablation: Follow‐up data from The Netherlands Heart Registration

Daniël Mol, Lisanne Renskers, Jippe C. Balt et al. · Journal of Cardiovascular Electrophysiology · 2022 · 34 citations · Full text

Medicine, Cardiology, Neurology +6

Ten-year experience with early angioplasty in 759 patients with acute myocardial infarction

Frits W. Bär, Jindra Vainer, J. Stevenhagen et al. · Journal of the American College of Cardiology · 2000 · 30 citations

Medicine, Cardiology, Internal Medicine +15

Three‐Dimensional CT Overlay in Comparison to CartoMerge for Pulmonary Vein Antrum Isolation

J. Stevenhagen, Pepijn H. van der Voort, Lukas Dekker et al. · Journal of Cardiovascular Electrophysiology · 2009 · 24 citations

Medicine, Cardiology, Radiology +17

COMPARE LAAO: Rationale and design of the randomized controlled trial “COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy”

Marina Huijboom, Moniek Maarse, Errol W. Aarnink et al. · American Heart Journal · 2022 · 17 citations · Full text

Medicine, Cardiology, Surgery +17